Showing results (1-10 of 143) with videos related to
Sort By:
Pageof 15
Seminars in Oncology|November 14, 2001
Farnesyltransferase inhibitorsS M Hahn, E Bernhard, W G McKennaSeminars in Radiation Oncology|October 26, 2001
Ras inhibitors and radiation therapyH A Jones, S M Hahn, E Bernhard, et al.The British Journal of Cancer. Supplement|July 1, 1996
Decreased ability of cells overexpressing MYC proteins to reduce peroxide and hydroperoxidesS Tuttle, R Muschel, E Bernhard, et al.Cancer Chemotherapy and Pharmacology|October 11, 2001
Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazolesC J Koch, S M Hahn, K Rockwell, et al.International Journal of Radiation Biology|October 8, 2003
Farnesyltransferase inhibitors as radiation sensitizersT B Brunner, A K Gupta, Y Shi, et al.Radiology|December 2, 1999
Non-small cell lung cancer: prognostic factors in patients treated with surgery and postoperative radiation therapyJ H Lee, M Machtay, L R Kaiser, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1994
Apoptosis and a re-investigation of the biologic basis for cancer therapyA V D'Amico, W G McKennaInternational Journal of Radiation Oncology, Biology, Physics|February 15, 2001
Hypoxia in human intraperitoneal and extremity sarcomasS M Evans, S M Hahn, D P Magarelli, et al.Pageof 15